|
Volumn 113, Issue 1, 2000, Pages 149-151
|
Letter to the editor [2] (multiple letters)
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CANCER CYTODIAGNOSIS;
CANCER GRADING;
CANCER SCREENING;
COST EFFECTIVENESS ANALYSIS;
FEMALE;
HUMAN;
HUMAN TISSUE;
LETTER;
MAJOR CLINICAL STUDY;
PAPANICOLAOU TEST;
PRIORITY JOURNAL;
RISK FACTOR;
UTERINE CERVIX CARCINOMA;
UTERINE CERVIX CARCINOMA IN SITU;
COST BENEFIT ANALYSIS;
ECONOMICS;
NOTE;
UTERINE CERVIX TUMOR;
VAGINA SMEAR;
CERVICAL INTRAEPITHELIAL NEOPLASIA;
COST-BENEFIT ANALYSIS;
FEMALE;
HUMANS;
UTERINE CERVICAL NEOPLASMS;
VAGINAL SMEARS;
|
EID: 0034089021
PISSN: 00029173
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (2)
|
References (0)
|